British American Tobacco p.l.c. (BATS) Earnings Call Transcript & Summary
February 13, 2025
Earnings Call Speaker Segments
Tadeu Marroco
executiveGood morning, everyone. It's a pleasure to have you join us for our 2024 Preliminary Results Presentation. Joining me this morning are Soraya Benchikh, our CFO, and Victoria Buxton, Group Head of Investors Relations. I'll start by covering the transformation highlights and the progress achieved throughout our investment year. After that, Soraya will walk you through the financial results in greater detail, and then I'll come back to discuss our performance outlook before we move to Q&A. Before going further, please direct your attention to the disclaimers on Slides 2 and 3. Let's start by examining the positive transformation momentum we are generating, beginning with a few highlights. 2024 marked a pivotal point in our transformation journey, as sharper execution allowed us to steer through near-term market difficulties and produce better performance in the second half. Group results came in line with expectations, and Soraya will cover those in more detail. Smokeless represents 17.5% of group revenue, which is 1 percentage point higher than last year. We gained 3.6 million smokeless consumers, bringing the total to 29.1 million, largely thanks to our ongoing success in Modern Oral. Our emphasis on quality growth — balancing delivery on both the top and bottom lines — has produced further improvement in new category contribution: an increase of GBP251 million, along with a 7 percentage point rise in our category contribution margin on an organic constant rates basis.
Tadeu Marroco
executiveWe're dedicated to giving shareholders solid cash returns, and I'm happy with how we've progressed in making our finances more flexible. That has allowed us to start a sustainable share buyback, keep making headway on leverage so it sits inside our target range at 2.4 times, and pair that with our progressive dividend, with 2% growth announced today. Our foundations are solid, and I'm confident that the choices we've made and the actions we've taken throughout our investment year are the right way forward for BAT. I've been clear that we needed to invest in order to strengthen our U.S. business, speed up innovation momentum, and boost capabilities that support our strategic delivery. There's more to do, but we are making clear progress. The commercial plans in the U.S. that we announced previously are complete, and I'm encouraged that our performance picked up in the second half. Thanks to our improved innovation ecosystem, our new category growth sped up in the second half, driven by Glo, Hyper Pro, and our refreshed Velo Mix in the U.S. Beyond that, we're excited about the Q4 launches of our latest innovations, including Velo Plus. As we highlighted before, we don't expect the road ahead to be linear. Later in the presentation, we'll share more detail on the key drivers and assumptions behind our 2025 guidance.
Tadeu Marroco
executiveOur commitment stands to get back to 3% to 5% revenue growth and 4% to 6% APFO growth in 2026, adjusted for Canada at constant rates. With that said, I'll pass things over to Soraya, who will walk you through our results in greater detail.
Soraya Benchikh
executiveThanks, Tadeu, and good morning, everybody. Before we get into the results and to frame things, I'd like to remind you of the main areas I'm focused on. First, fueling our transformation by getting the most sustainable value possible out of combustibles. Second, driving quality growth in new categories by putting capital to work in a disciplined way, going after the biggest profit pools and keeping a laser focus on returns. Third, strengthening our financial resilience. And although we've reached our target debt corridor, with Canada included in 2024, by 2026 we're aiming to be inside that corridor with Canada excluded, while staying committed to balanced capital allocation. With that in mind, I'd like to share how we progressed in 2024 as we turn to the results. I'm pleased to report that we delivered organic constant currency results in line with guidance. While our reported results reflect a number of adjusting items, including our exit from Russia and Belarus, a provision of GBP6.2 billion for Canada's CCAA proposed plan, a charge in Romania in respect of an excise assessment, and the GBP1.6 billion gain from the partial sale of our ITC investment. To understand the underlying performance, we'll focus on organic adjusted constant currency results.
Soraya Benchikh
executiveAdditional information about adjusting items can be found in the appendices. Accordingly, consistent with our guidance, group revenue was up 1.3%, revenue from new categories climbed 8.9%, and adjusted operating profit increased 1.4%. Diluted EPS also rose by 3.6%. Now, examining some of the main drivers <<inaudible>> combustibles price drives growth, with pricing nearly 9% higher, offset by next year. Adjusted gross profit grew by GBP400 million, helped by revenue growth management and scale benefits in new categories. Outside the U.S., we achieved revenue growth of 5.1% and operating profit growth of 7.5%. That underscores the strength of our multi-category portfolio and the resilience of our global footprint. As anticipated, new category revenue growth picked up pace in the second half. We delivered quality growth, with contribution margin increasing to 7%. This mirrors our targeted investment in high-value profit pools, disciplined focus on ROI and scaling benefits across markets. I'll now give more detail, and all shared data reflects full year averages unless otherwise stated, with further information again in the appendices. Let's begin with Vapor. Vapor is the biggest new category worldwide, with consumer numbers rising faster. Although category fundamentals remain strong, enforcement is weak against illicit single-use vapes in the U.S.
Soraya Benchikh
executiveAnd Canada has skewed the competitive landscape. Vapor revenue dropped 2.5%, and growth in Europe, driven by views, was offset by illicit market challenges. Views still holds the top value share worldwide and in the U.S., where we're showing solid financial resilience. U.S. volumes were down 4%, but they beat the 9% industry decline and track channels. Yet absent tougher enforcement, illicit vapor products will keep hitting the legal market. In AME, we kept value share leadership at 31.5%. Gains in France, Spain and Germany raised value share by 100 basis points, naturally, excluding Canada's losses stemming from Quebec's flavor ban. The UK and France, though, will probably see near-term disruption from single-use vapor bans in 2025, but we're well placed for long-term growth. In APMEA, revenue rose 24%, powered by strong momentum in South Korea and New Zealand. Turning to heated products. In heated products, industry growth decelerated, hit by rising new category poly usage in Europe. Glo revenue climbed nearly 6%, with a stronger H2 as anticipated. Growth came from the ongoing rollout of Glo Hyper Pro and better consumables, pushing the brand toward premium positioning. Glo Pro helped lift volume share with a modest dip of 40 basis points versus the 110 basis points in 2023.
Soraya Benchikh
executiveOver in Japan, Pro consumables picked up 110 basis points of volume share, which helped partly offset the drop in legacy super slims. In AME, category volume share leveled off, with solid gains in Poland and the Czech Republic plus ongoing improvement in Italy. Veo, our tobacco free range, keeps outperforming Pears by a wide margin. Glo's performance is now more balanced, with better category contribution in 2024 thanks to scale benefits and pricing. And finally, we come to Modern Oral, the new category that's growing fastest. Usage and daily consumption are climbing in both key and new markets, and non-traditional markets now account for 20% of industry volume. Modern Oral revenue was up 53% in 2024, with strong growth across every region and improving category contribution. Our category share rose, with volume share up 130 basis points. In AME, we led the Modern Oral category with 65% volume share, and Velo took 70% of category revenue growth. That result shows Velo is the category's leading brand and product. In the U.S., the recovery came from a refreshed Velo expression and the launch of Grizzly Modern Oral. We added more than two percentage points of volume share, hitting 6.6% and 18% in New York in December, where this mix was first introduced.
Soraya Benchikh
executiveToward the close of the year, we added Velo Plus to our U.S. portfolio, and Tadeu will cover that in more detail later. Within combustibles, organic volumes fell 5%, largely because of the U.S. market exits, and supply chain problems in Sudan weighed on results as well. Leaving those out, volume was down 3.5%. Volume share rose 20 basis points, helped by solid results in Brazil, Bangladesh, Mexico, and Pakistan. Value share fell 20 basis points, with the U.S. driving that drop. Our U.S. commercial investments in H1 helped us regain volume and value share during the second half. Revenue came in slightly higher, as growth in AME and APMEA — and within APMEA, led by Brazil, Japan, and Turkey — more than offset the U.S. Moving now to the regions: U.S. revenue was 3.4% lower, chiefly because of the commercial actions taken over the last 18 months. Alongside persistent macroeconomic pressure on affordability and illicit vapor products hitting both combustibles and vapor, the combustibles industry on a sales to retail basis fell roughly 9%. If you exclude deep discount, a segment where we have no presence, the industry was down 11%, while our volume declined 10.1%. New category poly-usage accounted for 4% of the industry decline, and illicit vapor made up 2.5% of that.
Soraya Benchikh
executiveU.S. financial results got better as the year went on, helped by solid combustible performance compared with 2023. Adjusted operating profit declined 3.5%, reflecting reduced combustible volume along with commercial investment. Tadeu will share more U.S. details later. Turning to AME, this is a region spanning multiple categories, and smokeless revenue now accounts for 24% in markets where we have new categories. In 11 of those markets, smokeless products now deliver more than 50% of revenue. Revenue was up almost 5%, powered by greater combustibles revenue on healthy volume and robust pricing, plus double-digit growth in new categories, with Modern Oral rising 47%. Vapor revenue fell, largely because of Canada, while adjusted operating profit increased 7.5% as scale advantages in new categories and cost savings more than offset inflation. In APMEA, growth picked up in H2, and smokeless products now make up 20% of revenue in markets where we offer new categories. Total revenue rose 5.4%, with combustibles ahead 3.5% on pricing gains, partly offset by declines in Australia and supply chain disruptions in Sudan. New category revenue climbed almost 9%, led by vapor and Modern Oral gains in emerging markets, and heated products benefiting from innovation and lapping Japan's prior year commercial plans.
Soraya Benchikh
executiveAdjusted operating profit rose 7.5%, helped by pricing plus better performance in Japan, asset sales, and efficiency gains. Now the group operating margin came in flat, since we offset inflation and ForEx pressures through higher new category profitability and cost savings. BAT has a solid record of delivering cost savings. Having reached close to GBP900 million in savings across the last two years, we remain on track to deliver more than GBP1.2 billion by year end. Those savings helped offset inflation and ForEx impacts while funding quality growth investments. In 2024 we absorbed GBP390 million in inflationary costs and 1.1% transactional FX headwinds on adjusted operating profit. Inflationary pressures are expected to ease this year. Beyond 2025 we aim to simplify combustibles and drive scale benefits and new categories targeting an additional GBP2 billion in savings by 2030. EPS grew 3.6%. Gains from lower net finance costs and share count were partly offset by our reduced share of ITC profits and tax. The underlying tax rate was 24.9% and we expect around 25% in 2025 based on prevailing rates. Operating cash conversion exceeded 100% for the fifth year reflecting our strong cash discipline. In 2025 we anticipate GBP650 million of gross CapEx and GBP1.8 billion net finance costs adjusted for Canada.
Soraya Benchikh
executiveOur debt profile is solid: 87% of net debt is fixed, with an average maturity of just under 10 years and close currency matching. We brought leverage down to 2.4 times, which, adjusted for Canada, would be 2.75 times. We expect to be back inside our target leverage range of 2 to 2.5 times after court approval and implementation of the proposed plans by the end of 2026. We back the proposed CCAA settlement, which maximizes value for claimants while securing our continued operation in Canada. In accounting for the proposed settlement, we will continue to fully consolidate our Canadian business in accordance with IFRS. We have recognized a GBP6.2 billion provision in our 2024 reported results, and this is treated as an adjusting item in line with our accounting policies. To ensure that the P&L reflects the economic delivery from Canada from 2025, we will report APFO adjusted for Canada. Now, given the uncertainty of the timing of the settlement in 2025, our non-GAAP reported numbers will remove 100% of our Canadian business excluding new categories, with 2024 comparators provided on the same basis in the appendices. It is important to note that we will continue to fully consolidate our revenue in Canada.
Soraya Benchikh
executiveThat's contingent on the settlement being finalized in 2025. Starting in 2026, we'll make an adjustment to take out 85F of our Canadian APFO, consistent with the charging schedule, excluding new categories, which we'll bring down to 80% at 5 years after settlement and to 75% at 10 years after settlement. Following six years and CCAA protection, we're pleased to have arrived at this point, and the accounting treatment we've laid out today reflects where the proposed plan currently stands. We're hopeful for a quick resolution and stay committed to our capital allocation priorities. BAT generates a great deal of cash, and we expect more than GBP50 billion of free cash flow across 2024 to 2030. Our capital allocation priorities remain unchanged: first, reinvesting in our transformation while balancing deleveraging and progressive dividends and sustainable share buybacks, plus selective bolt-on M&A to speed up that transformation. Going forward, we anticipate meaningful headwinds in Bangladesh and Australia. In January, Bangladesh's interim government raised VAT and supplementary duty on more than 100 essential products, tobacco among them. Excise has climbed sharply, combined with above-inflation floor price increases across every category, and that's expected to speed up illicit trade. In Australia, new tobacco regulations — the largest reform since plain packaging in 2012 — take effect from April 1.
Soraya Benchikh
executiveAlso, the recent one-off excise hikes — the most recent being last September — are already speeding up the fall in industry volume. In the past year, illicit trade rose 6% points, reaching 36% of industry volume, while smoking incidence stayed steady across the last five years. Add vapor incidence, which sits at nine percent right now, and that means roughly 65% of nicotine usage in Australia is illicit. Going forward, we anticipate that this ineffective government policy will push legal industry volume down even faster, and combined with the announced incremental effect of one more excise increase in September, it will keep significantly driving illicit trade. Taken together, we expect these two headwinds — in Australia and in Bangladesh — to hit our 2025 group revenue growth by 1% and group APFO growth by close to 2%, with the January budget in Bangladesh being the main factor behind the change since our December trading update. Consequently, and with these impacts included in 2025, we expect to deliver revenue growth of around 1%, supporting APFO growth of 1.5% to 2.5% adjusted for Canada and including a 1.5% transactional FX headwind. The main drivers are an improving U.S. financial performance returning to growth despite continued macro and illicit trade headwinds, another solid AME performance, and further strong growth from Velo globally.
Soraya Benchikh
executiveWe also anticipate growing APFO faster than revenue this year, alongside the planned rollout of exciting innovations across all three new categories, backed by ongoing strong contributions from new category growth, an intense focus on ROI, and additional cost savings. For both revenue and profit, we expect group performance to be weighted toward the second half, as we roll out those new category innovations over the course of the year, with first-half results reflecting progress in the U.S. led by combustibles and Modern Oral, offset by combustible headwinds as described in APMEA, plus the ongoing absence of enforcement in the U.S. and Canada and the Mexico vapor ban. As we emphasized at our Capital Markets Day, we'll keep monitoring key KPIs across every pillar to gauge how successfully our transformation is going. To sum up, 2024 was a year of investment, and I'm glad to see that progress showing up in our key metrics. Dashboards have been rolled out across business units to improve decision making. These dashboards center on our transformation to deliver long-term growth, return on investment, ensuring financial discipline and cash flow, and leverage to preserve financial strength. I'm confident these metrics will help us generate sustainable shareholder value. With that, I'll turn it back to Tadeu.
Tadeu Marroco
executiveThanks, Soraya. Now I'd like to take a few moments to lay out the road ahead. With our multi-category strategy and global footprint, BAT is transforming, and in a growing industry we're well positioned. I believe the right strategy, the right capabilities and the right people are in place to deliver a profitable transformation, while also delivering strong returns to shareholders and making progress toward our vision of building a smokeless world. At our Capital Market Day in October, I shared these 10 key reasons why I fundamentally believe in the future growth prospects of BAT. Soraya has touched on many of the broader themes, and I'd like to now share some additional color on our confidence in these six key areas highlighted in the slides. First, BAT is well positioned within the value of the nicotine industry, which is growing at an accelerated pace as consumers around the world increasingly switch to new categories. Second, we have transformed our entire innovation ecosystem. This has allowed us to step change our product portfolio based on our consumer insights. We have developed an exciting innovation pipeline across our new categories that we will deploy in a target way through 2025. As highlighted at our CMD, Glo Hilo is a breakthrough system that we believe will reshape the way Glo is positioned in the category, allowing us to compete effectively in the premium segment that represents over 80% of industry value.
Tadeu Marroco
executiveBack in November, we brought our first two-piece premium device to Serbia. Insights and learnings are being gathered, and the results in those markets so far have us encouraged. Hilo, along with our new consumables Vivto and Rebo <<inaudible>>, is connecting strongly with most of the acquired consumers who are new to the Glo brand family. Further updates will come as this exciting new platform keeps rolling out from mid-2025. On vapor, our first move toward giving consumers premium vapor products will be Views Ultra — an untapped opportunity that accounts for only 3% of vapor category value today. Views Ultra is a fresh vapor solution that delivers a responsible, high quality and satisfying experience for vapor consumers, and it positions Views as a brand consumers can trust. Rollout on a targeted basis starts this quarter in Canada and will carry on through the year. Modern Oral in the U.S. keeps growing strongly, and the progress with our existing portfolio that Soraya highlighted makes me pleased. Going forward, I'm excited about expanding the portfolio with Velo Plus, launched at the end of last year in seven flavors and two nicotine strands. Velo Plus carries higher moisture, and early results are very encouraging — including strong uptake fueled by adult consumer demand and trial, with our total volume share of Modern Oral above 10% in the latest reading.
Tadeu Marroco
executiveWe'll keep the rollout going through the first half, with a complete activation plan spanning retailer, media and digital platforms. Another reason for confidence comes from how our business in Europe has grown and delivered, since over a third of all nicotine consumers there are actively using new categories. Thanks to our focus on quality growth, new categories have proved to be game changers for what we deliver in Europe, as these charts illustrate. Growth in new categories has allowed our European business to surpass our group mid-term revenue guidance and has also made possible significant increases in absolute category contribution through scale and efficiencies. A further reason for confidence is our U.S. business, which stays the cornerstone of our future. As we highlighted at our CMD, one-third of the global adult nicotine value pool sits here, with the industry still expanding quickly. It encourages me that the investment approach we've taken over the last 18 months to strengthen our business is working. In combustibles, we have broadened our contracted distribution universe to 88% coverage, producing a 3.2% point gain in volume share in these newly contracted outlets, with share gains across our brands. Beyond that, this has produced a 1.2 percentage point decline in the deeper discount segment in these outlets.
Tadeu Marroco
executiveWhen it comes to premium, we've put money behind Newport soft pack in the key investment states, which gives us a lettered portfolio. Beyond that, we've delivered steady value share gains both in premium with Natural American Spirit and in branded value with Lucky Strike, and that brand is still the fastest growing cigarette brand in the market. One thing that has really defined our industry over recent years is how strong the deep discount segment has been, with consumers trying to stretch their dollars further. During 2024, we've observed a deceleration in deep discount volume growth. Meanwhile, branded value has picked up volume share, and BAT has grown its share of that segment, led by Lucky Strike. The lower-end adult consumer is plainly still under pressure, but we think these segment dynamics, together with better consumer confidence levels, show some early signs of movement toward recovery, and that would give us a tailwind over the medium term. Going forward, so that we can get an even sharper read on market performance, we're moving to a retail sales data share rate with enhanced coverage, which lifts both the quality and the speed of our decisions and which we expect will help us sharpen our execution. We're starting to see returns on the investments in the U.S. that we had already planned and have now completed.
Tadeu Marroco
executiveSo as we shift toward creating value, our overall volume share held steady in 2024. If you set aside the deep discount segment, where we don't compete, our volume share rose by 40 basis points. Worth noting: 95% of the U.S. combustible value pool lies outside that deep discount segment, and we think we've turned a significant corner, with the U.S. back in growth, and we look forward to delivering further improvement to our group performance in 2025 and 2026. On the regulatory side, we're encouraged that a possible menthol ban has been withdrawn and prior rulemaking frozen while the new administration reconsiders proposed regulations, very low nicotine among them. In new categories, what we've achieved in Europe shows we can compete effectively when the regulatory playing field is level. And we keep working hard to make that happen in the U.S. by pushing for more appropriate enforcement of regulation, particularly in vapor. Over the course of 2024, we saw the FDA step up enforcement action. That said, legal products can only succeed if the FDA does more to go after illicit vapor. To back that effort, we keep advocating for a PMTA list to be published, which would give clarity to every market participant.
Tadeu Marroco
executiveBeyond that, the U.S. International Trade Commission is still looking into the patent infringement complaint we filed about those illicit products. On the state side, legislation for vapor directories or enforcement has passed in 14 states as of now, which means roughly 30% of tracked vapor industry volume will fall under state directories once this year ends. Louisiana stands as a strong illustration of what well-crafted regulation paired with proper enforcement can accomplish. After implementation there, the legal vapor market in Louisiana saw volume rise 33%, while single-use illicit products in tracking channels dropped 91%. <<inaudible>> keeps capturing most of the volume flowing back to the legal segment. Meanwhile, at the national level, illicit vapor products keep hurting the legal market. That trend sped up legal industry declines toward the close of last year, and we anticipate it will carry on through 2025. Although we remain hopeful that government engagement efforts will produce a fairer competitive environment eventually, we don't anticipate those efforts will meaningfully affect our near-term results. Naturally, enforcement of effective regulation isn't only a U.S. priority for us. Through decades of work, we've developed substantial expertise and capability in this space, linking science, corporate, and regulatory affairs toward a sustainable future.
Tadeu Marroco
executiveWe've set up Omni, which pulls together scientific evidence to shift how a wider set of stakeholders sees tobacco harm reduction. Our firm conviction is that regulators ought to welcome tobacco harm reduction guided by science and supported by strong enforcement, so that the decline in smoking prevalence speeds up. Any regulator that stays on the sidelines here won't just delay the pace of transformation society requires — we're also witnessing fast expansion in illicit products. Drawing on science and Omni, we're taking a more proactive approach to engaging regulators around the world, and there's encouraging movement on regulatory change in certain areas. And we'll keep amplifying our message. Now, from the day I became Chief Executive, I've been clear that, building on our foundations of integrity, collaboration, and inclusivity, we will shape the culture required to transform BAT successfully. With our 2030 people strategy as our guide, we're already achieving strong progress. Our workforce is highly engaged and committed, and our refreshed values are landing powerfully. Our employer value proposition is drawing in talent, and we're likewise moving forward on our diversity and inclusion agenda — all toward a single aim: driving a cultural transformation that makes us an exciting and winning company for a better tomorrow.
Tadeu Marroco
executiveBefore we wrap up, I’d like to lay out what we’re focused on for 2025. As you can see, priority one is our emphasis on quality growth, so that we introduce new innovations in a targeted manner while balancing delivery on both the top and bottom lines. We’re committed to generating value from our combustible business. That’s essential to funding our transformation, and the U.S. will be a major driver here. We’ll step up our proactive stance on regulatory affairs, powered by science and the Omni. All of this will be carried out with a returns focus, in terms of both cash generation and continuing to establish a track record of delivery. In 2025, I’m confident we will build on our foundations. As Soraya pointed out, our 2025 guidance incorporates significant combustible headwinds in Bangladesh and Australia. Combined, these account for a 1% impact on group revenue and close to 2% on group EPFO, which is already reflected in our guidance. Looking ahead to 2026, I’m confident we will build on our underlying momentum through 2025 to deliver 3% to 5% revenue growth and 4% to 6% EPFO growth adjusted for Canada on a constant currency basis. We expect the main drivers to include further improvement in our U.S.
Tadeu Marroco
executiveOur financial results, which were helped by a backdrop that was less negative from industry volume, the macro environment, and stronger enforcement against illicit vapor. Second, quality growth that comes from our new category innovations. And third, lapping the 2025 combustibles headwinds in Bangladesh and the investments in our innovation rollout. And fourth, a step up in efficiencies through our GBP2 billion savings programs to 2030. While more remains to be done, I have confidence that the right strategy, capabilities, and people are in place to deliver profitable transformation. I'm excited about what lies ahead for BAT, and I believe we will deliver long-term sustainable growth and value for all our stakeholders. Thank you for listening. Victoria will now join us on stage for the question and answer session. Victoria, please.
Victoria Buxton
executiveThanks, Tadeu and Soraya, and good morning, everybody. <<operator_script>> Tadeu and Soraya will be glad to take your questions, so at this point I'll turn things over to the conference call operator.
Operator
operatorThanks a lot, Victoria. Our first question today comes from Faham Baig at UBS. Go ahead, your line is open.
Faham Baig
analystMorning, everyone. Thanks for letting me ask questions. I'd like to take the liberty of asking three, please—two of them are clarifications. I want to begin with the U.S., please. I believe you mentioned twice in your remarks that you expect a recovery in the U.S. financial performance and a return to growth despite continuing to assume a challenging environment from a macro perspective and illicit vape enforcement. So could you maybe clarify some of the factors that will result in the U.S. growing, and I presume that means revenue growth and profit growth. I'd like to start there.
Tadeu Marroco
executiveYou're right about that, Farham. We do expect the U.S. to return to growth. In combustible, we've had three tough years — 2022, '23, and '24. The past two years have essentially been an investment period for us to get back to where we should be. We fixed and put money into several areas that I laid out in my presentation. Clearly, we'll be lapping a lower base in 2024. That's one reason the comparator will be a lower base in '24. On top of that, we'll be building on the positions I just showed in terms of where we stand on market share. There's great momentum behind the Luck Strike brand, and Newport has stabilized as well. And now, with all the lettering we've done. We believe that with the trade coverage expansion I referred to, plus the digital capabilities we've been investing in, we have more of an expectation that we'll return to positive territory in 2025. On the new categories, clearly Velo Plus is performing extremely well. And as I said, this will strongly support progress in the categories in the U.S.
Tadeu Marroco
executiveThe worry we have, as I framed it, is that we don't anticipate a big shift in how the legal vapor market behaves. That's going to be a headwind in 2025, and our hope is to offset it through the new categories in more than our specifically. So on the whole, we expect the U.S. to return to growth starting in 2025.
Faham Baig
analystThanks, Tadeu. I'd like to focus for a moment on Velo Plus. Can you confirm whether Velo's volume share stood at 10% in the most recent reading? And what figure would apply to just Velo alone? It would also help if you could give some perspective on where we stand regarding distribution for this product. Where do we anticipate it heading? What's our situation on capacity? I'd also like your perspective on how you see moist and wet pouches compared with the dry products already offered in the U.S. Which kinds of consumers are drawn to it? And in your view, is the U.S. consumer ready to move from dry to wet?
Tadeu Marroco
executiveSo from that 10% I mentioned—actually a bit over 10% from the most recent reading—Velo Plus makes up roughly 7%, 7% of that figure. The Velo trifecta, which is the internal project we refer to as the refreshed Velo launch from last year, accounts for 3%, 3.5%. What we've observed regarding Velo's growth is that no more than 30%, 35% comes from our prior Velo. That means the bulk arrives from outside the earlier Velo, and in New York we're now nearing a 20% reading once you factor in both Velo Plus and the prior one. And clearly, moisture is the standout feature of Velo Plus. We find it connects with every kind of consumer, since we use greater moisture outside the U.S. in markets with traditional oral—meaning consumers arriving from snus and certain other oral products, plus consumers coming from cigarettes or vapors. So moisture is a crucial feature and the primary force behind that. We've now built our presence across roughly 75,000 outlets in the U.S., and we intend to reach 110 outlets starting in April, which is actually the second quarter of the year.
Faham Baig
analystGreat, that's very clear. And then I have one question, I suppose, probably just a clarification. I do want to revisit Bangladesh and this roughly 1 percentage point hit to profit that you're dealing with there. I suppose I'd like to take you back 2 years, and take you to Pakistan, where you had, I guess, an even bigger excise tax hike, an even bigger price increase. Volumes fell to 33% in 2023. But your profits, if I'm not wrong, actually rose 33% in local currencies. So what makes Bangladesh different? Why do you expect profits to fall in that market with this price increase?
Tadeu Marroco
executiveOkay, so let me walk you through Bangladesh. Typically, an excise policy comes out around mid-year, in June. What happened here is that the government, under pressure to boost tax collection, chose to make an ad hoc increase—not only on cigarettes, but they raised VAT and duties on over 100 products, cigarettes included. On top of that came an excise hike across every tier point, including the above-inflation floor price. So really, it comes down to affordability, because consumers were already struggling—like many consumers around the world—with the cost of living, rising food prices, food price inflation, and then on top of all that they had to deal with price increases on 100 products, and we had to raise cigarette prices across the board to cope with those excise increases. Now, that accounts for most of the 1 percent impact. There's also the Australia case that we highlighted. But what we observed—and Pakistan is a good example—is that when geographies go too far with excise shocks, they'll find that this works counterintuitively to their goal of raising tax collection, because what happened is exactly the opposite in the second year.
Tadeu Marroco
executiveOnce a legal market was in place, the government made efforts to soften the situation and took certain steps aimed at preventing it from recurring. That is also the assumption we are working with for 2026 — that we will be lapping in ’25 and won’t see that impact extend any further in ’26, since in Bangladesh 10% of all tax collection comes from tobacco, which tells you how dependent they are on it. They simply cannot afford to watch illegal markets expand over successive years. That is the point I was making about the lapping in 2025.
Faham Baig
analystThanks, Tadeu. That means a lot to me.
Operator
operatorMuch appreciated for those questions, Mr. Baig. At this point we’ll turn to Rashad Kawan at Morgan Stanley. Sir, the floor is yours — your line is open.
Rashad Kawan
analystHey, good morning, guys. Thanks for taking my questions. I've got two, please. So, the first one — I know it's still relatively early, but you reiterated getting to your midterm guide by 2026. I guess what gives you confidence that you can achieve that? How much of an improvement does that assume in U.S. combustibles volumes and enforcement and illicit vapes? And then the second question, you talked about sustainable buybacks again today. And again, as you think about 2026, should we assume buybacks will continue irrespective of the Canadian settlement? I know you obviously have some flex from the ITC hotel stake, but potentially could you also look to monetize more of the ITC stake there to fund future buybacks? I guess just any thoughts around how that fits within your capital allocation priorities would be helpful. Thank you.
Tadeu Marroco
executiveThank you for that question. Sorry, I’m going to step away from that and address the capital allocation question instead. Regarding 2026 — well, we just discussed Bangladesh, and that makes up the bulk of the 1%. Underlying revenue growth for ’25 would have come in at roughly 2%, which is essentially consistent with what we envision on this path toward our midterm algorithm in 2026. So, as I just laid out in response to our question, we expect to be lapping that during 2025. And the other point is that, clearly, we have invested in a full overhaul of our innovation ecosystem across 2024. The reason we describe 2025 as a deployment year is that, over the course of the year, we’ll be rolling out these new initiatives. Glo Hilo, for instance, is a very different product from the one we currently have. So we will meaningfully raise our competitiveness in tobacco heating products. Vilo Plus in the U.S. now adds to what is already a highly successful and winning product we have outside the U.S. in the fastest growing new category in the world today, which is Modern Oral. It’s rising in incidence and rising in every daily consumption in every market where we launch this product. And we are clearly a leader in that space.
Tadeu Marroco
executiveAnd on vapor as well, we’ll be focused on establishing a premium — essentially creating a premium subcategory in vapor through our new product. So as we get to 2026, all of those products are already on the market. That means we’ll get a full year of benefit from the products that launch across 2025. So that’s another factor. In the U.S., we anticipate a more supportive macroeconomic backdrop that will translate better for low-income consumers, who have been hit hard over the last few years by very high inflation and interest rates. So across 2025, we expect those macro conditions to be more supportive for low-income consumers. And we genuinely believe the new administration will attempt to tackle a huge problem we have in the U.S. today: the proliferation of illegal vapor products, which currently represents more than 7% of the total U.S. vapor market, because this truly benefits no one. It doesn’t benefit U.S. consumers, who lack access to the latest innovative smokeless products. It doesn’t benefit states that could have been collecting tax. It doesn’t benefit consumers who lack access to high-quality products when nobody knows exactly what is in those products, and it doesn’t benefit the legal players, because we don’t have a level playing field.
Tadeu Marroco
executiveI do think that's true. Now, clearly, the reason we set the range at 3 to 5 for revenue and 4 to 6 for operating properties is precisely to account for those variations. Should things exceed what we expect, we'll land nearer the top end of that range. If they fall short of what we expect, we'll sit at the bottom end of it. But we'll have a clearer picture on that as 2025 unfolds.
Soraya Benchikh
executiveMay I add one point? Today you mentioned the revenue effect for 2025 — 1% from Bangladesh and Australia — while on APFO it is a 2% impact. If you factor that against our 1.5% to 2% guidance, then underlying it becomes 3.5% to 4.5%. Okay, turning to your question about sustainable buybacks in 2026. As Tadeu said, in 2026 we will return to our 3 to 5, 4 to 6 growth algorithm. And as I said earlier in the presentation, once Canada is excluded, leverage comes to 2.75 times. So on capital allocation in 2026, our aim is to get back inside our leverage corridor of 2 to 2.5. And we will keep balancing cash returns between, basically, our progressive dividend policy. We announced 2% this year, and we will stick with that policy, because after meeting many of our shareholders, I know how highly they value the dividends. But we will also look at — we will be generating sufficient cash. I think it was mentioned at the CMD that once we hit our midterm algorithm, we will be generating roughly GBP8 billion of cash per annum.
Soraya Benchikh
executiveSo that gives us enough room to balance a progressive dividend policy with a buyback that's sustainable — a share buyback. So to answer your question, yes, we'll be aiming to keep that up. Just to remind you, we've recently finished a GBP700 million share buyback, and we're committed to carrying out a GBP900 million share buyback this year.
Rashad Kawan
analystThanks a lot. That's really clear.
Operator
operatorMuch appreciated, sir. At this point we’ll turn things over to Gaurav Jain at Barclays. The floor is yours.
Gaurav Jain
analystMorning, Tadeo. Good morning. I’ve got three questions too. First, regarding the ITC hotel stake: I believe you hold 15% of that company directly. What are your plans for it?
Tadeu Marroco
executiveAs I've mentioned before, Gaurav, BAT isn't looking to remain a long-term holder of an Indian hotel chain. So when the timing is right — and we'll determine when that moment best maximizes shareholder value — we will divest, and the proceeds will go toward ensuring we reach a leverage corridor of 2.5 to 2 by 2026.
Gaurav Jain
analystAbsolutely, thanks. On the second point, regarding heated tobacco specifically, I do hear the remarks about a new platform coming to market this year. That said, I'm aware there was a divestiture involving Russia and Ukraine, which has actually reported figures as we view them. If you focus solely on APMEA numbers—mostly Japan and Korea—it looks flat, while competitors have clearly expanded at a much, much faster pace. So do you think you'll be able to speed up that growth to match the market's rate?
Tadeu Marroco
executiveRight, yes. So what's going to happen in Japan through 2024 — we had a legacy system there, a super-slim product. That system was essentially fully swapped out for Glo Hyper. And we actually raised the price to speed up that shift from super-slim to demi-slim, which is the entire Glo Hyper lineup. So because of that, you haven't really seen much change when it comes to volumes or revenue growth. But ultimately, we know Glo Hyper Pro is a far more appealing platform than the old super-slim we had before. Retention is higher, average daily consumption is higher, and it connects with consumers on brand attributes in a much stronger way than the prior one did. So that's essentially the Japan story for 2024 in Hyper. And it has affected performance across the whole region, since the bulk of HP in the region comes out of Japan. And of course, with Glo Hilo, as we mentioned, that isn't happening until the middle of the year. But in the second half, we expect to round out today's offer with something much more improved, and our expectation is that we'll be in a far better position to make stronger inroads when it comes to category share of tobacco heating products.
Gaurav Jain
analystAbsolutely. My final question concerns the U.S. market. So in FY’24, your revenue fell 3.5%. Cigarette volume is down 10%, revenue is down 4%, so clearly your pricing has trailed what the industry leader there was taking. Therefore, when you say FY’25 U.S. revenues will be flat, it's more or less that pricing on combustibles will now begin aligning with the industry leader. Should I think about it that way?
Tadeu Marroco
executiveWe’re not in a position to discuss pricing, Gaurav. As I mentioned earlier, though, we’ll be up against a softer comparison, since we had to make those investments we talked about and had to reposition the brands so they fit better with what the U.S. consumer is actually experiencing. All of that carries consequences for the company’s top line. What matters, however, is that these initiatives have now been completed, and we enter 2025 with a different dynamic.
Gaurav Jain
analystI really appreciate it.
Operator
operatorAppreciate that, Mr. Jain. Next we’ll turn things over to Rey Wium Anchor SB. The floor is yours.
Rey Wium
analystHello there, Tadeu and Soraya. Let me just briefly zero in on how things stand in Canada. On this point, I'd simply like to find out if the yearly settlements that are going to come through — and I realize it's somewhat early to say — will be deductible for tax purposes for ITCAT <<inaudible>>?
Soraya Benchikh
executiveSure. Right now, it's just a proposed plan, I mean. I'm sure you can appreciate how large and complex the settlement is. But our early read at this point is that they'll be tax deductible. Obviously, though, we'll get more clarity once the settlement is finalized.
Rey Wium
analystGood. Now, another thing I find interesting is the overall settlement figure — CAD32 billion — which clearly has to be paid out across the years using profits. Is there some minimum liability you have to bear? Suppose, for example, that cigarette consumption falls so quickly that Canada becomes smoke-free, say, 10 years from now. And say the payments have built up to roughly CAD20 billion. Would there be a top-up you'd have to make, industry-wide, for the remaining CAD12 billion, for example?
Soraya Benchikh
executiveNo, there isn't a minimum liability. The provision we recorded in the accounts this year, CAD6.2 billion, essentially breaks into two amounts: CAD3.7 billion is clearly our estimate of the liability, and CAD2.5 billion is the cash we currently hold. But clearly, depending on how the industry evolves, that's what will be paid out. Still, our best estimate is the CAD3.7 billion, obviously on a discounted basis.
Rey Wium
analystGreat. And have you more or less settled on what portion of these payments your company will receive among the major players in the industry?
Soraya Benchikh
executiveLike I mentioned, that's the estimate we have right now—our present figure for what the liability would come to. And the upcoming milestones in this case: by March 3, the judge has to either sign off on the plan, or else we return to negotiations. After that there's a 21-day window for an appeal, during which the judge must approve the grounds for that appeal. Those are essentially the next steps. Under IFRS, of course, that figure is our estimate. Sorry—please go ahead.
Rey Wium
analystYeah, let me just address the Australia situation quickly. In recent years, that market has fallen at a significant pace. I mean, from what your competitor has said, the market came in at essentially 5 billion sticks in 2024. So I just want to ask: is Australia still profitable for you? And how long are you able to keep operating in a market that keeps shrinking before you might also choose to leave it?
Tadeu Marroco
executiveSo yeah, look — this is obviously a fresh policy approach that we're actually witnessing play out. And sadly, in this instance, I'd say Australia has turned into one of those outliers globally. As we mentioned earlier today, 65% of nicotine consumption is already legal in Australia. How many countries can you name in this kind of very, very extreme situation — you could tally them on a handful of fingers, right? And our hope is that at some point the authorities will acknowledge this and do something about it. Because ultimately, it isn't only about tax collection dropping dramatically — we also know these illegal operations invariably go hand in hand with other criminal activity. And beyond that, take what's happening in vaporware, where basically 100% is illegal. Control will be entirely lost when it comes to youth access, when it comes to what consumers are using, since these products have very questionable quality standards. So we're hoping the government wakes up to this and takes some action on it. And that's why we continue to back the country and our people there.
Tadeu Marroco
executiveNaturally, it remains profitable—if it weren't, we wouldn't have seen that effect on our 2025 figures. The truth, though, is that we're hoping these matters can shift as soon as they're able to grasp what the actual situation is.
Rey Wium
analystAlright, thanks so much.
Operator
operatorThanks for the question, sir. At this point we'll hand things over to Damian McNeela at Deutsche Numis. The floor is yours.
Damian McNeela
analystMorning, Tadeu. Morning, Soraya. I realize a couple of U.S. questions have already come up, but I'd like some clarification. Some of what needs to improve for you in the U.S., I think, stems from factors beyond your control, such as the U.S. consumer and illicit trade. So to clarify: in your FY’26 return to the growth algo, is it right that the bottom end of the range is driven by everything within your control in the U.S., while the top end of the range would gain from factors outside your control? That's my first question. My second question: could you give us any quantitative or qualitative data on what drove the improvement in new category profit contribution during the period, broken out by subcategory, please? Those are my two questions.
Tadeu Marroco
executiveThanks. So, the first question doesn't quite operate that way, but I was attempting to frame it in the same spirit as what you've just outlined. And in 2026, our figures will comfortably sit inside that range, or at its upper end, if we get genuinely meaningful enforcement on the vapor business, for instance, plus better macroeconomic conditions. That said, as I mentioned, we already anticipate 2025 being the year when the U.S. turns the corner and becomes a more supportive business for the rest of BAT. So we're confident we can hit the 3 to 5 range, and 4 to 6 in '26, and should we be surprised by stronger enforcement or a better macro picture than our plans assume, we could in fact land more toward the upper end of that range. Do you want to take the —
Soraya Benchikh
executiveYeah, regarding how the new category profitability has improved, if we look at the main drivers, first, we've supported the top line through RGM as we move forward. And we've also managed to optimize cost of sales by driving scale. As a result, you'll see in the results that gross margin in new categories has actually accreted by 500 basis points. Moving further down to contribution, we've also been able to work on return on investment by focusing on the largest profit pools — so reallocating resources toward those largest profit pools — but also we've been driving across the whole business, across every business unit, dashboards with data analytics to support decision making, plus a marketing spend effectiveness program that we've started to roll out. And hopefully over the course of this year we'll roll it out across the group. And that really has been supporting the delivery and the contribution. As all of you have seen, we've delivered more than GBP250 million in category contribution. We're up to 7%, and there's a lot more to come. We'll stay on this trajectory, enhancing contribution. If I had to call out a few of the categories, I think in HP, in tobacco heating products, we drove a particularly better contribution there through RGM, as I mentioned, supporting the top line and taking some pricing, but also cutting losses on devices and benefiting from scale.
Soraya Benchikh
executiveModern Oral is, as you’re aware, a very profitable category, and in vaping we keep working to improve profitability by concentrating on the premium segment of vaping while we roll out our innovations down the line.
Damian McNeela
analystThat's quite clear. Thanks so much.
Operator
operatorThanks, Damian. Ladies and gentlemen, we’re at the final audio questions for today, and the people joining us by phone will be Richard Felton of Goldman Sachs. Please go ahead.
Richard Felton
analystThanks a lot, and good morning, everyone. I have three questions, if I may. First, regarding the illicit vapor category beyond the U.S.: I'd like to hear any thoughts or observations about what you're seeing in your markets when it comes to illicit vape growth. I know much attention is focused on the U.S., but are there other markets showing a similar pattern, and does that affect your willingness to invest in that category? Second, can you highlight anything about phasing within your guidance? I know the statement describes it as second half weighted, but can you quantify that in any way? And third, apologies if I missed it, but could you remind us what the new tobacco regulation in Australia actually is? Thank you.
Tadeu Marroco
executiveAll right. When it comes to the illicit vapor category, the two biggest issues we're dealing with right now are essentially the U.S. and Canada, given how large the vapor market is there. In Canada, keep in mind that Quebec has announced a ban on every flavor except tobacco, but with no enforcement attached. And the very next day, you get the identical situation as in the U.S.: illegal products flowing in, flavors returning to stores, thousands of puffs, and absolutely no control over the quality of what's being sold. Those, I'd say, are the two biggest ones. Clearly, there are places where matters are far better contained. Take France — vapor is sold through tobacconists, a more controlled setting, since a retail license is required. That's the reason the discussions we're having here in the UK matter: we advocate very strongly for a retail license. Hopefully the government will act on this in the final act tied to it. Then there's New Zealand, where vapor has been handled very well and has had a very positive effect in lowering cigarette incidence and moving toward a far more controlled rise in vapors.
Tadeu Marroco
executiveBut we also see situations such as Australia, which I just mentioned—there, 100% of illegal trade and 9% of population consumption is essentially all illicit vape. Or places like Malaysia, which have also opened up but without enforcement. What matters most is that we don't abandon this category, because if you look at how many consumers use these smokeless products, vapor is by far the biggest category and holds great potential to move smokers away from cigarettes and to shift those who wish to keep using nicotine toward a much lower risk of doing so. Still, this requires proper regulation along with proper enforcement. That is why I place so much emphasis on Omni—we aim to spark this debate across the various jurisdictions where we operate. And some of them do listen to what we say. We have just seen Chile approve vapor in the marketplace, beginning in a few weeks. So we want to work as closely as possible with policy holders so as not to lose this opportunity, which could deliver a tremendous positive impact on public health.
Tadeu Marroco
executiveSo that's what we're seeing in illicit vapor—obviously a challenge. And our approach around moving into and building a more premium segment within vapor is also tied to this proliferation of products in certain markets where enforcement still isn't there. On your question about the second-half weighting, the benefits from all these new launches will come more toward the second half, and a lot of that relates to what I mentioned about Glo Hilo. Hilo was the first opportunity BAT has actually had to take part in the premium side of the tobacco heating product category. And this will obviously be a creative for the company. But it's all arriving in the second half of the year. Then the other innovations we discussed—Velo Plus is performing extremely well. Obviously, by the second half they'll be more established in the market. So that will be supportive as well. So those are the reasons we expect—because most of the revenue, and going back to the 3 to 5, 4 to 6, is being driven by new categories. That's been the case at BAT for some time now. We've talked about this before.
Tadeu Marroco
executiveOf those 3, revenue from combustible products has to deliver somewhere between 0% — roughly flat — and 2%. Everything else is going to come out of the new categories. Pretty much the same picture applies on the APFO line, where the range is 1% to 2% to 3%. The bulk of that gap is expected to be driven by new categories. And this is one thing we are going to keep seeing increasingly going forward, as new categories become increasingly important to our business. The new legislation in Australia is the most significant — it represents the largest change since the plain package was introduced in 2012. It covers a range of measures, including new health warnings on the stick. Different pack formats have been eliminated, for instance. And obviously that comes on top of the continuation of this ad hoc exercise, in addition to the inflationary exercise that takes place in the first half of the year. So, clearly, the illegal market faces none of that. And that is among the reasons the illegal trade is climbing sharply in Australia. Now, just to put — I would like to take this chance to invite all of you to take a more holistic view.
Tadeu Marroco
executiveOf course, issues will always pop up here and there, yet plenty of opportunities exist too. Having a portfolio that spans multiple geographies and multiple categories is a strength for BAT, and it helps us cushion some of the pressures that arise in certain locations. We witnessed this right back during COVID, when the other two regions were hit hard and the U.S. propped things up by performing extremely well. More recently, the U.S. has been moving through an investment phase, and both of those reasons were highlighted today in the 2024 results as stepping up. Combustibles are going through a difficult stretch and the new category is offsetting that. So that is a dynamic a company like BAT is fully capable of navigating. And I have great confidence that, with all the foundations we built in ‘24 and with ‘25 being a transition year, we will be able to return in ‘26. And the beauty of it — we mentioned Canada — at some point we would need a definition of Canada. Under IFRS, deconsolidating Canada was never possible for us. We have explained this previously. At a certain stage, this would be happening at certain moments.
Tadeu Marroco
executiveWe've made the decision to act on this now, in '25, since we think there's a decent chance a solution might land in '25. Even so, the clouds are clearing. We previously had a U.S. mental band that appears increasingly remote, and a U.S. low-nic cap that also appears increasingly remote. Whether we'll ever return, I hold serious doubts on that. But this amounts to, in practice, a tobacco ban — effectively a tobacco ban within the U.S., and this administration would never go along with it. We harbored plenty of doubts regarding our capacity to generate profit from new categories when we were carrying over a billion in losses on the P&L. As of today, new categories deliver a 7% operating margin. In only four years, that's a swing from a GBP1.1 billion loss to GBP0.3 million of positives. We've established a leading brand in Modern Oral within the fastest-growing of our new categories. We've fully overhauled our innovation portfolio, and we have a far more competitive product in tobacco heating product, which starts making a difference from 2025 onwards. And we likewise possess a firmly established vapor business that, provided we tackle the enforcement elements we were discussing, would place us in a strongly leading position to gain from that.
Tadeu Marroco
executiveOf course, leverage has been a worry, and we’ve shown we’re able to lever the company up to the targets we require. So I’d like to ask you to take that holistic view, because I believe that matters quite a bit.
Victoria Buxton
executiveThanks, Tadeu. Unfortunately, we've run out of time for today. If we didn't get to your question, please feel free to reach out to the IR team, and we'll assist you directly. That said, I'd like to give it back to Tadeu for a few closing remarks.
Tadeu Marroco
executiveThanks to everyone for tuning in today and for submitting your questions. In closing, I'm glad we've posted 2024 results that match expectations. There's still work ahead, but I have confidence that the investment steps we've taken are the correct path forward for BAT as we build momentum across 2025 to deliver our medium-term algorithm in 2026. We'll keep rewarding shareholders with strong cash returns, including our progressive dividend and sustainable share buyback, and we'll build on our foundations to deliver long-term growth and value creation. Thanks once more for joining us — I look forward to updating you on our progress at our half-year results.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete British American Tobacco p.l.c. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to British American Tobacco p.l.c. earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in British American Tobacco p.l.c. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.